Donate Advertising Contact

FDA Approval 10/23/20 9a Ci

FOSTER CITY BASED GILEAD SCIENCE’S DRUG REMDESIVIR (remdes-e-vir-) IS THE FIRST DRUG TO BE APPROVED BY THE FOOD AND DRUG ADMINISTRATION TO TREAT THE DEADLY CORONA VIRUS.

 GILEAD SCIENCES CALL THE NEW DRUG “VEKLURY” AND IT REDUCES THE RECOVERY TIME FROM COVID 19 BY FIVE DAYS… FROM 15 DAYS OF SICKNESS TO 10, ON AVERAGE.

 BUT A DOSE OF REMDESIVIR WILL NOT COME CHEAP. GILEAD TYPICALLY CHARGES  2,340 DOLLARS FOR A TREATMENT COURSE FOR PEOPLE COVERED BY GOVERNMENT HEALTH PROGRAMS IN THE UNITED STATES… AND  3,120 FOR PATIENTS WITH PRIVATE INSURANCE. 

 

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *